Priority at the European Patent Office
Yesterday, in a high-profile case relating to CRISPR technology, the EPO confirmed its practice regarding the validity of priority claims.
US China Trade Deal
The trade deal signed this week between the US and China is interesting from an Intellectual Property perspective.
Regen Lab v Estar Medical
Following the Supreme Court’s decision in Actavis V Eli Lilly and the first application of the reformed Improver questions for infringement in Icescape v Ice-world, a further judgement from HH Judge Hacon has provided a second example of the test bei
Cleveland Scott York’s top tips on how to trade mark a medical device
Our top tips for effectively protecting marks in the medical devices sector split into recommendations which apply generally in relation to all industries, and those which are sector-specific.
The historic patent story of the stent
A stent is a small mesh tube that is placed in a narrow or weak artery as part of a procedure called percutaneous coronary intervention (PCI) to improve the blood flow, support the inner walls of the artery and help prevent them from bursting.
The historic patent story of the MRI scanner
Since 1970, Magnetic Resonance Imaging (MRI) has played a key role in the medical world.
EPO and Patents Court decisions clash in patent validity dispute.
English Patents Court* grants Novartis a preliminary injunction against generics company Dr Reddy’s in respect of patented breast cancer drug, providing a provisional validity opinion that is inconsistent with co-pending opposition proceedings at the
No direction on the issue of direct infringement for Swiss-form claims
Beyond the matter of sufficiency in the Warner-Lambert pregabalin case, the UK Supreme Court unanimously decided that there would have been no infringement had the claims in question been valid.